CYCLOPHOSPHAMIDE
Active substance: cyclophosphamide
INJECTION, POWDER, FOR SOLUTION · CYCLOPHOSPHAMIDE 2 g/100mL
United StatesActive
Marketing holder: Baxter Healthcare Company
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
Composition
- CYCLOPHOSPHAMIDE · 2 g/100mL
Registration
- Registration number
- 10019-942
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS, ORAL
Sources
- product · openFDA NDC · 10019-942 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 10019-942 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 10019-942 · Verified 2026-10-09 · open in source